|
|
|
|
|
|
|
Could Your CTR Approval Take Just Six Weeks?
|
The EU Clinical Trial Regulation is often perceived as a source of delay. Yet, with early planning, aligned processes and experienced research sites, trial applications can be authorised in as little as six weeks. Discover which factors have the greatest impact on timelines and submission success. Read the article.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scaling Investigational Drug Services
|
|
Case Study | McCreadie Group
|
Are operational bottlenecks holding back your research site? Explore a blueprint for automating investigational product workflows and giving staff time back for patient care.
|
|
|
|
|
|
De-Risking FIH: Integrated Strategies For Rapid Proof-Of-Concept
|
|
Article | By Andreas Reichl, M.D., and Kevin Schaab, Ph.D., Quotient Sciences
|
Proper planning for first-in-human studies is crucial to successful drug development, which requires innovative trial designs and sound CMC strategies to mitigate risk and expedite proof-of-concept.
|
|
|
|
|
|
|
|
Reviewing Protocols Across Therapeutic Areas
|
|
Product | BRANY
|
A successful clinical trial starts with an efficient protocol review.
With deep roots in academic research and clinical medicine, BRANY IRB is uniquely positioned to meet your cost and speed requirements. Get your clinical trial to the start line while ensuring participant health and safety.
|
|
|
|
|
|
Safety And Regulatory Compliance Solutions
|
|
Datasheet | IQVIA Safety & Regulatory Compliance
|
IQVIA offers a complete approach that combines safety, regulatory, quality, and medical information to transform and sustain compliance.
|
|
|
|
|
|
|
|
ISPOR Europe 2026
|
In an era defined by rapid scientific advancement, fiscal pressures, evolving regulations, and growing expectations for equity and transparency, health economics and outcomes research (HEOR) provides the frameworks and insights needed to guide responsible and sustainable healthcare decision making. Thousands of global healthcare stakeholders will convene at ISPOR Europe 2026 to underscore the transformative role of HEOR in guiding better healthcare decisions.
|
|
|
|
|
|
|
|
5 Ways To Enrich The Clinical Trial Ecosystem
|
|
Guest Column | By Efthymia Kostaki
|
Sponsors must treat sites, PIs, and patients as connected parts of a living clinical trial ecosystem. Here are five ways to help make that happen.
|
|
|
|
|
|
The ctDNA Clinical Trial Advantage
|
|
Article | Veristat, Inc.
|
See how CROs are helping shape the future of ctDNA research—translating emerging data, regulatory insights, and biomarker innovation into faster, smarter oncology development.
|
|
|
|
|
|
Reducing Human Variability in Bioanalysis
|
|
Article | Dash Bio
|
Automation removes manual variability, creating consistent, repeatable processes that improve precision, strengthen compliance, and produce more reliable data for critical decisions.
|
|
|
|
|
|
|
|
Portfolio Optimization Strategic Consulting
|
|
Product | Parexel International
|
For each prospective compound, we help you think through its clinical implications, safety parameters, and side effects to establish what will differentiate it in the current market landscape.
|
|
|
|
|
|
Life Sciences Meetings Need More Than Logistics
|
|
Article | Scout
|
Life sciences meetings often extend beyond investigators’ meetings. Strong planning helps teams support clinical, commercial, governance, and internal programs without adding pressure.
|
|
|
|
|
|
FSP: Global Support To Fit Clinical Trial Management Needs
|
|
Product | Worldwide Flex
|
Worldwide Flex provides flexible, scalable solutions and services to enhance our clients’ outsourcing needs. We are a specialized provider of multi-therapeutic functional solutions delivered by our experts.
|
|
|
|
|
|
Starting A New Study? This One's For You
|
|
Brochure | By Kalyan Obalampalli, ClinAI
|
Choosing the right vendor at trial launch impacts costs, timelines, data integrity, and patient experience — yet vendor selection in clinical research remains fundamentally broken today.
|
|
|
| Connect With Clinical Leader: |
|
|
|
|